MOSt Market Outlook
8th September 2017
Nifty Chart
Nifty Outlook
Index
CMP
R1
R2
S1
S2
Nifty Cash
9930
9980
10020
9880
9850
BankNifty
24304
24500 24750 24150 24000
Nifty index opened positive and headed towards 9965 mark,
but it failed to hold its gains and corrected towards 9920
levels. It formed a small candle and got stuck in the broader
trading range of 9850 to 9980 zones from last seven trading
sessions. It closed positive with the gains of 14 points near
to its key level of 9928. Now it has to continue to hold above
9928 zones to witness an up move towards 9980 while on
the downside supports are seen at 9880 then 9850 levels.
Currency (USDINR) Outlook
USDINR
64.16
S1
63.80
S2
63.65
R1
64.05
R2
64.25
Market Drivers
Indian indices closed flattish. Stocks like Eicher,
Indiabulls housing, Bajaj Finance, Mahindra did
see gains but stocks like ITC dragged down the
market. Select Pharma stocks did see some pull
back. In mid-caps, stock specific action continued
though the mid cap index closed flat as well.
Flows continue to remain mixed with FIIs
continuing to be net sellers. Asia is trading mixed.
Sectors like financials, metals and auto continue
to look positive. Infrastructure, defense space
remains interesting. Larsen remains the
preferred play to participate in the likely pick up
in infrastructure. Cement as a space could also
continue to see investment interest as it will be
key beneficiary.
Trading Idea - Cash & Future
Scrip
HINDALCO
Reco
Buy
CMP
250
SL
245
Target
260
Sideways consolidation within 63.80 - 64.05 is expected
for the session.
Sectoral Outlook
Sector
NBFC
METALS
Outlook
POSITIVE
POSITIVE
Highest Call OI
Instrument
Nifty 28 - Sep
Bank Nifty 28 - Sep
Bank Nifty 7 - Sep
Strike
10000
24500
25000
OI
4714350
943640
390040
Chg in OI
386550
323360
270560
Corporate Action:
Dividends -
ABHIJIT, ANDREWYU, AROGRANITE, BIGBLOC,
DAAWAT, GRASIM, KRBL, MANAKINDLTD, MARATHON,
ORIBEVER, ORIENTREF, POKARNA, SANCTRN, SWASTIKA,
THEBYKE, VICTMILL, VMART, WHIRLPOOL
Trading Idea - Derivatives
STRATEGY UPDATE : AXIS BANK RATIO BULL CALL SPREAD
Instrument
B/S
Lot
Reco
CMP
AXIS BANK CE 510
AXIS BANK CE 520
AXIS BANK CE 530
Buy
Sell
Sell
1
1
1
10.75
6.75
3.95
5.75
3.90
1.75
Highest Put OI
Instrument
Nifty 28 - Sep
Bank Nifty 28 - Sep
Bank Nifty 7 - Sep
Strike
9700
24000
24000
OI
5040675
847880
391640
Chg in OI
356700
38560
259520
Security in Ban period:
IBREALEST, JSWENERGY, JUSTDIAL
Today Event
NA
Stop Loss : 3000; Target : 6000

MOSt Market Outlook
8th September 2017
Trading Calls
HINDALCO
Buy
CMP :
Target :
INR 250
INR 260
Derivatives Idea
AXIS BANK
RATIO BULL CALL SPREAD
Buy 1 Lot 510 CE
Sell 1 Lot 520 CE
Sell 1 Lot 530 CE
Price breaks out of a small ascending triangle. The prior trend
is up and an ascending triangle being a continuation pattern
suggests that the prices are likely to see more upsides in com-
ing sessions
3
Metal stocks are on a roll and we are expecting this stock to
rally towards 260, thus suggesting to buy at current levels with
a stop below 245
3
3
3
3
3
3
It has been respecting to its multiple support of 500 zones from
last nine sessions
It has the behaviour to move in a range bound manner
Maximum Put OI at 500 strike could support it to hold above 500
zones
Maximum Call OI at 520 strike could restrict its upside momen-
tum
Thus low cost Ratio Bull Call Spread is recommending
FII & DII Activity (INR in Cr)
FII F&O
6th Sep
-1353
52
5th Sep
-379
474
Institution
INDEX FUTURES
INDEX OPTIONS
STOCK FUTURES
Net B/S
-107
1,517
-275
OI
Short Built Up
Put Buying
Short Built Up
Cat.
FII
DII
7th Sep
-564
245

MOSt Market Outlook
8th September 2017
Long Built-up
Short Built-up
Long Unwinding
Short Covering
Nifty Option OI
1- Day change in Nifty OI

MOSt Market Outlook
8th September 2017
Research Notes
Morning Meet Notes
Shree Cement - Annual Report: Expanding footprint in new regions - (CMP18480, TP22360, Recom BUY)
o Diversification strategy; adding capacity (up to 6.4m tonnes in the East & 3m tonnes in the South)
o Aggressive capacity addition program continues (by ~32% over the next two years)
o Capex cost remains lowest in the market (capex per tonne of USD32)
o Cost leadership maintained (unitary cost of power & fuel declined by ~6%)
o Securing resources for sustainable growth in the East
o We value it at TP of INR22360 (15x FY20E EV/EBITDA)
Healthcare - Brace for impact: Significant changes in Draft Pharma Policy
o Draft Pharma Policy out - suggested changes concern stakeholders
o First step toward transitioning from branded generic to trade generic market
o Requirement of BA/BE studies and focus on quality control to increase cost
o One manufacturer, one salt, one brand name and one price
o Diluting powers of NPPA, Capping of trade margins, Unfair marketing practice,
o Draft policy in current form can lead to double whammy

MOSt Market Outlook
8th September 2017

MOSt Market Outlook
8th September 2017
Currency Ideas
USDINR
EURINR
3
3
USDINR continued its weakness for the second session closing at 64.16.
Immediate support is at 63.80 - 63.70 area whereas resistances are pegged at
64.05 / 64.25.
Sideways consolidation within 63.80 - 64.05 is expected and either side breach
could be decisive.
3
Immediate support for the pair is at 77.00 followed by 76.65 and bias will
remain positive as long as price stays above the same.
The pair is likely to test 77.60 - 77.80 levels in short-term.
3
3

MOSt Market Outlook
Chandan Taparia
Research Analyst (Derivatives & Technical Analyst)
Disclosures
The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations).
Motilal Oswal Securities Ltd. (MOSL) is a SEBI Registered Research Analyst having registration no. INH000000412. MOSL, the Research Entity (RE) as defined in the Regulations, is engaged in the business of providing Stock broking services,
Investment Advisory Services, Depository participant services & distribution of various financial products. MOSL is a subsidiary company of Motilal Oswal Financial Service Ltd. (MOFSL). MOFSL is a listed public company, the details in respect of
which are available on
www.motilaloswal.com.
MOSL is registered with the Securities & Exchange Board of India (SEBI) and is a registered Trading Member with National Stock Exchange of India Ltd. (NSE) and Bombay Stock Exchange Limited
(BSE), Metropolitan Stock Exchange Of India Ltd. (MSE) for its stock broking activities & is Depository participant with Central Depository Services Limited (CDSL) & National Securities Depository Limited (NSDL) and is member of Association
of Mutual Funds of India (AMFI) for distribution of financial products. Details of associate entities of Motilal Oswal Securities Limited are available on the website at
http://onlinereports.motilaloswal.com/Dormant/documents/Associate%20Details.pdf
Pending Regulatory Enquiries against Motilal Oswal Securities Limited by SEBI:
SEBI pursuant to a complaint from client Shri C.R. Mohanraj alleging unauthorized trading, issued a letter dated 29th April 2014 to MOSL notifying appointment of an Adjudicating Officer as per
SEBI regulations to hold inquiry and adjudge violation of SEBI Regulations; MOSL requested SEBI to provide all documents, records, investigation report relied upon by SEBI which were referred
in Show Cause Notice and also sought personal hearing. The matter is currently pending.
MOSL, it's associates, Research Analyst or their relative may have any financial interest in the subject company. MOSL and/or its associates and/or Research Analyst may have beneficial ownership of 1% or more securities in the subject company
at the end of the month immediately preceding the date of publication of the Research Report. MOSL and its associate company(ies), their directors and Research Analyst and their relatives may; (a) from time to time, have a long or short position
in, act as principal in, and buy or sell the securities or derivatives thereof of companies mentioned herein. (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker
in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related
information and opinions.; however the same shall have no bearing whatsoever on the specific recommendations made by the analyst(s), as the recommendations made by the analyst(s) are completely independent of the views of the
associates of MOSL even though there might exist an inherent conflict of interest in some of the stocks mentioned in the research report. Research Analyst may have served as director/officer, etc. in the subject company in the last 12 month
period. MOSL and/or its associates may have received any compensation from the subject company in the past 12 months.
In the last 12 months period ending on the last day of the month immediately preceding the date of publication of this research report, MOSL or any of its associates may have:
a) managed or co-managed public offering of securities from subject company of this research report,
b) received compensation for investment banking or merchant banking or brokerage services from subject company of this research report,
c) received compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company of this research report.
d) Subject Company may have been a client of MOSL or its associates during twelve months preceding the date of distribution of the research report.
MOSL and it's associates have not received any compensation or other benefits from the subject company or third party in connection with the research report. To enhance transparency, MOSL has incorporated a Disclosure of Interest Statement
in this document. This should, however, not be treated as endorsement of the views expressed in the report. MOSL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports.
As a result, the recipients of this report should be aware that MOSL may have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not based on any specific merchant banking,
investment banking or brokerage service transactions. may have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not based on any specific merchant banking, investment banking
or brokerage service transactions.
Terms & Conditions:
This report has been prepared by MOSL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential and may not be altered in any way, transmitted to, copied or
distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of MOSL. The report is based on the facts, figures and information that are considered true, correct, reliable and
accurate. The intent of this report is not recommendatory in nature. The information is obtained from publicly available media or other sources believed to be reliable. Such information has not been independently verified and no guaranty,
representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. The report is prepared solely for informational purpose and does
not constitute an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers may receive this report
at the same time. MOSL will not treat recipients as customers by virtue of their receiving this report.
Analyst Certification
The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related
to the specific recommendations and views expressed by research analyst(s) in this report.
Disclosure of Interest Statement
Analyst ownership of 1% or more securities
No
A graph of daily closing prices of securities is available at
www.nseindia.com, www.bseindia.com.
Research Analyst views on Subject Company may vary based on Fundamental research and Technical Research. Proprietary trading desk of MOSL
or its associates maintains arm's length distance with Research Team as all the activities are segregated from MOSL research activity and therefore it can have an independent view with regards to subject company for which Research Team have
expressed their views.
Regional Disclosures (outside India)
This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would
subject MOSL & its group companies to registration or licensing requirements within such jurisdictions.

MOSt Market Outlook
For Hong Kong:
This report is distributed in Hong Kong by Motilal Oswal capital Markets (Hong Kong) Private Limited, a licensed corporation (CE AYY-301) licensed and regulated by the Hong Kong Securities and Futures Commission (SFC) pursuant to the
Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) "SFO". As per SEBI (Research Analyst Regulations) 2014 Motilal Oswal Securities (SEBI Reg No. INH000000412) has an agreement with Motilal Oswal capital Markets
(Hong Kong) Private Limited for distribution of research report in Hong Kong. This report is intended for distribution only to "Professional Investors" as defined in Part I of Schedule 1 to SFO. Any investment or investment activity to which
this document relates is only available to professional investor and will be engaged only with professional investors." Nothing here is an offer or solicitation of these securities, products and services in any jurisdiction where their offer or sale
is not qualified or exempt from registration. The Indian Analyst(s) who compile this report is/are not located in Hong Kong & are not conducting Research Analysis in Hong Kong.
For U.S.
Motilal Oswal Securities Limited (MOSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States. In addition MOSL is not a registered
investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific
exemption under the Acts, any brokerage and investment services provided by MOSL, including the products and services described herein are not available to or intended for U.S. persons. This report is intended for distribution only to "Major
Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are
not major institutional investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption
from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with
Institutional Investors based in the U.S., MOSL has entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International Private Limited. ("MOSIPL"). Any business interaction pursuant to this report
will have to be executed within the provisions of this chaperoning agreement.
The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer, MOSIPL, and therefore, may not be
subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account.
For Singapore
Motilal Oswal Capital Markets Singapore Pte Limited is acting as an exempt financial advisor under section 23(1)(f) of the Financial Advisers Act(FAA) read with regulation 17(1)(d) of the Financial Advisors Regulations and is a subsidiary of Motilal
Oswal Securities Limited in India. This research is distributed in Singapore by Motilal Oswal Capital Markets Singapore Pte Limited and it is only directed in Singapore to accredited investors, as defined in the Financial Advisers Regulations and
the Securities and Futures Act (Chapter 289), as amended from time to time. In respect of any matter arising from or in connection with the research you could contact the following representatives of Motilal Oswal Capital Markets Singapore
Pte Limited:
Disclaimer:
The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media
or reproduced in any form, without prior written consent. This report and information herein is solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for
securities or other financial instruments. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances. The securities
discussed and opinions expressed in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This may not
be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities
of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable
for all investors. Certain transactions -including those involving futures, options, another derivative products as well as non-investment grade securities - involve substantial risk and are not suitable for all investors. No representation or warranty,
express or implied, is made as to the accuracy, completeness or fairness of the information and opinions contained in this document. The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the
transparency and should not be treated as endorsement of the views expressed in the report. This information is subject to change without any prior notice. The Company reserves the right to make modifications and alternations to this
statement as may be required from time to time without any prior approval. MOSL, its associates, their directors and the employees may from time to time, effect or have effected an own account transaction in, or deal as principal or agent
in or for the securities mentioned in this document. They may perform or seek to perform investment banking or other services for, or solicit investment banking or other business from, any company referred to in this report. Each of these
entities functions as a separate, distinct and independent of each other. The recipient should take this into account before interpreting the document. This report has been prepared on the basis of information that is already available in publicly
accessible media or developed through analysis of MOSL. The views expressed are those of the analyst, and the Company may or may not subscribe to all the views expressed therein. This document is being supplied to you solely for your
information and may not be reproduced, redistributed or passed on, directly or indirectly, to any other person or published, copied, in whole or in part, for any purpose. This report is not directed or intended for distribution to, or use by,
any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSL to
any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come
are required to inform themselves of and to observe such restriction. Neither the Firm, not its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including
lost revenue or lost profits that may arise from or in connection with the use of the information. The person accessing this information specifically agrees to exempt MOSL or any of its affiliates or employees from, any and all responsibility/
liability arising from such misuse and agrees not to hold MOSL or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSL or any of its affiliates or employees free and harmless from all losses, costs,
damages, expenses that may be suffered by the person accessing this information due to any errors and delays.
Registered Office Address: Motilal Oswal Tower, Rahimtullah Sayani Road, Opposite Parel ST Depot, Prabhadevi, Mumbai-400025; Tel No.: 022-3980 4263; www.motilaloswal.com. Correspondence Address: Palm Spring Centre, 2nd Floor,
Palm Court Complex, New Link Road, Malad (West), Mumbai- 400 064. Tel No: 022 3080 1000. Compliance Officer: Neeraj Agarwal, Email Id:
na@motilaloswal.com,
Contact No.:022-30801085.
Registration details of group entities.: MOSL: NSE (Cash): INB231041238; NSE (F&O): INF231041238; NSE (CD): INE231041238; BSE (Cash): INB011041257; BSE(F&O): INF011041257; BSE(CD); MSE(Cash): INB261041231; MSE(F&O):
INF261041231; MSE(CD): INE261041231; CDSL: IN-DP-16-2015; NSDL: IN-DP-NSDL-152-2000; Research Analyst: INH000000412. AMFI: ARN 17397. Investment Adviser: INA000007100. Motilal Oswal Asset Management Company Ltd.
(MOAMC): PMS (Registration No.: INP000000670) offers PMS and Mutual Funds products. Motilal Oswal Wealth Management Ltd. (MOWML): PMS (Registration No.: INP000004409) offers wealth management solutions. *Motilal Oswal
Securities Ltd. is a distributor of Mutual Funds, PMS, Fixed Deposit, Bond, NCDs, Insurance and IPO products. * Motilal Oswal Commodities Broker Pvt. Ltd. offers Commodities Products. * Motilal Oswal Real Estate Investment Advisors II Pvt.
Ltd. offers Real Estate products. * Motilal Oswal Private Equity Investment Advisors Pvt. Ltd. offers Private Equity products